文献速递脊柱外科小儿骨科

多模式疼痛管理方案减少青少年特发性脊柱侧凸后路脊柱融合术患儿术后阿片类药物使用的证据

Evidence for a Multimodal Pain Management Regimen in Reduction of Postoperative Opioid Use in Pediatric Patients Receiving Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis.
PubMed 文献 · Spine (Phila Pa 1976) · 2023-06-09

该回顾性队列研究纳入2018年1月至2022年9月在儿童医院及区域三级转诊中心接受后路脊柱融合术(融合节段>5)的10至17岁青少年特发性脊柱侧凸患者,评估术中非阿片类镇痛药、肌肉松弛剂和麻醉药用量增加与术后结局的关系。结果显示,三级转诊中心患者接受等量或更多非阿片类药物,术后阿片类药物用量减少20%,下床活动时间提前(19.3 vs 22.3小时),住院时间缩短(35.9 vs 58.3小时),术后疼痛评分无显著差异。

要点

  • 术中非阿片类药物用量更大的患者术后阿片类药物用量减少20%。
  • 该组患者下床活动时间提前(19.3 vs 22.3小时),住院时间缩短(35.9 vs 58.3小时)。
  • 术后非阿片类镇痛药在降低主观疼痛评分方面与阿片类药物同样有效。

核心结论

  • 接受更多术中非阿片类药物的患者术后吗啡毫克当量用量减少20%,出院时间提前22.3小时,且更早记录到活动证据。
  • 术后非阿片类镇痛药在降低主观疼痛评分方面与阿片类药物同样有效。
  • 本研究进一步证明多模式疼痛管理方案在青少年特发性脊柱侧凸后路脊柱融合术患儿中的有效性。

研究设计与样本

  • 回顾性队列研究,回顾性病历审查2018年1月至2022年9月期间在儿童医院及区域三级转诊中心接受后路脊柱融合术(融合节段>5)的10至17岁青少年特发性脊柱侧凸患者。
  • 采用线性回归模型评估基线特征和术中药物对术后接受的吗啡毫克当量总量的影响。

主要发现

  • 两组患者背景特征无显著差异。
  • 三级转诊中心患者接受等量或更多的所有非阿片类镇痛药,下床活动时间缩短(19.3 vs 22.3小时),术后阿片类药物用量减少(56.1 vs 70.1 MME),术后住院时间缩短(35.9 vs 58.3小时)。
  • 医院地点与术后阿片类药物使用差异无独立关联。
  • 术后疼痛评分无显著差异。
  • 纳入所有其他变量后,脂质体布比卡因对术后阿片类药物用量减少的贡献最大。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY DESIGN: Retrospective cohort study. OBJECTIVE: This project aims to evaluate the relationship between increased use of intraoperative nonopioid analgesics, muscle relaxers, and anesthetics and postoperative outcomes, including opioid utilization, time until ambulation, and hospital length of stay. SUMMARY OF BACKGROUND DATA: Adolescent idiopathic scoliosis (AIS) is a structural deformity of the spine that occurs in otherwise healthy adolescents, occurring with a frequency of 1% to 3%. Up to 60% of patients receiving spinal surgeries, particularly posterior spinal fusion (PSF), experience at least 1 day of moderate-to-severe pain after surgery. PATIENTS AND METHODS: This is a retrospective chart review of pediatric patients aged 10 to 17 having received PSF with >5 levels fused for AIS at a dedicated children's hospital and a regional tertiary referral center with a dedicated pediatric spine program between January 2018 and September 2022. A linear regression model was used to evaluate the influence of baseline characteristics and intraoperative medications on the total amount of postoperative morphine milligram equivalents received. RESULTS: There were no significant differences in the background characteristics of the two patient populations. Patients receiving PSF at the tertiary referral center received equivalent or greater amounts of all nonopioid pain medications and demonstrated decreased time until ambulation (19.3 vs . 22.3 h), postoperative opioid use (56.1 vs . 70.1 MME), and postoperative hospital length of stay (35.9 vs . 58.3 h). Hospital location was not individually associated with a difference in postoperative opioid use. There was not a significant difference in postoperative pain ratings. When accounting for all other variables, liposomal bupivacaine had the greatest contribution to the decrease in postoperative opioid use. CONCLUSION: Patients receiving greater amounts of nonopioid intraoperative medications utilized 20% fewer postoperative morphine milligram equivalents, were discharged 22.3 hours earlier and had earlier recorded evidence of mobility. Postoperatively, nonopioid analgesics were as effective as opioids in the reduction of subjective pain ratings. This study further demonstrates the efficacy of multimodal pain management regimens in pediatric patients receiving PSF for AIS.

来源:Spine (Phila Pa 1976),查看原文。版权归原作者所有。

引用

  1. Collis RW, Dry T, Ray HE, et al. Evidence for a Multimodal Pain Management Regimen in Reduction of Postoperative Opioid Use in Pediatric Patients Receiving Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis. Spine (Phila Pa 1976). 2023. PMID: 37294836. doi:10.1097/BRS.0000000000004747

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。